Revolo Biotherapeutics

Biotechnology Research • Gaithersburg, Maryland, United States • 11-20 Employees

Company overview

Headquarters	9711 Washingtonian Blvd, Gaithersburg, Maryland 20878, US
Websites	revolobio.com immuneregulation.com
NAICS	541714
SIC	873
Founded	2011
Employees	11-20
Socials

Key Contacts at Revolo Biotherapeutics

Woody Bryan

President And Chief Executive Officer

Marla Persky

Member Board Of Directors

Carrie Vincent

Director, Human Resources And Senior Executive Administration

Lara Ravanetti

Associate Director R&D

Revolo Biotherapeutics Email Formats

Revolo Biotherapeutics uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@revolobio.com), used 66.7% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@revolobio.com	66.7%
{first name}{last name}	johndoe@revolobio.com	16.7%
{last name}	doe@revolobio.com	16.7%

About Revolo Biotherapeutics

Revolo Biotherapeutics is developing revolutionary therapies powered to reset the immune system to achieve superior long-term remission for patients with autoimmune and allergic diseases. Its two drug candidates, ‘1805 and ‘1104, a protein and a peptide respectively, reset the immune system by preventing the chronic pro-inflammatory immune response that results in autoimmune or allergic disease. ‘1805 is a modified analogue of a key molecule in immune function and is in clinical development for moderate-to-severe rheumatoid arthritis and non-infectious uveitis. ‘1104 is a peptide derived from a natural immune-regulatory protein and is in clinical development for patients with eosinophilic esophagitis (EoE) and allergic disease. The disease-agnostic mechanism of action of Revolo Biotherapeutic’s assets provides a potential platform for the development of treatments for multiple autoimmune and allergic diseases. Visit www.revolobio.com to learn more.

Revolo Biotherapeutics revenue & valuation

Annual revenue	$1,711,100
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$5,500,000
Total funding	$52,000,000

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

Director

C-Suite

Employees by Department

Revolo Biotherapeutics has 8 employees across 5 departments.

Departments

Number of employees

Funding Data

Explore Revolo Biotherapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2020-10-21	5	$52,000,000

Funding Insights

$52,000,000

Total funding amount

$52,000,000

Most recent funding amount

Number of funding rounds

Revolo Biotherapeutics Tech Stack

Discover the technologies and tools that power Revolo Biotherapeutics's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

Astra

WordPress themes

Slick

JavaScript libraries

Swiper

JavaScript libraries

jQuery UI

JavaScript libraries

Elementor

Page builders

jQuery Migrate

JavaScript libraries

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Adobe Fonts

Font scripts

Frequently asked questions

Revolo Biotherapeutics is located in Gaithersburg, Maryland, US.

Revolo Biotherapeutics was founded in 2011, making it 15 years old. The company has established itself as a significant player in its industry over this time.

Revolo Biotherapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Revolo Biotherapeutics has raised a total of $52,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Revolo Biotherapeutics

Woody Bryan

President And Chief Executive Officer

Marla Persky

Member Board Of Directors

Carrie Vincent

Director, Human Resources And Senior Executive Administration

Lara Ravanetti

Associate Director R&D

4.8

40,000 users